Search

Your search keyword '"Positron Emission Tomography"' showing total 3,409 results

Search Constraints

Start Over You searched for: Descriptor "Positron Emission Tomography" Remove constraint Descriptor: "Positron Emission Tomography" Publication Type News Remove constraint Publication Type: News
3,409 results on '"Positron Emission Tomography"'

Search Results

3. New Epstein-Barr Virus Study Findings Have Been Published by Researchers at Capital Medical University (Enhancing diagnostic precision in EBV-related HLH: a multifaceted approach using 18F-FDG PET/CT and nomogram integration)

5. Jubilant Pharmova arm to expand PET radiopharmacy network in US; invests $50 Million.

6. Tau Blood Test Flags Preclinical Alzheimer's Disease.

7. Federal Grant Of $3 Million Allocated For Lung Infections Study Led By Indian American.

8. US FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer

9. New blood test accurately detects Alzheimer's disease

12. GE expands advanced imaging activities in Israel

13. Nawaz to be hospitalized for treatment

14. Dr Yasmin talks under pressure: Marriyum

15. An eye exam could detect early signs of Alzheimer's

16. After US withdrawal from Iran nuclear deal, restored sanctions put cancer patients at risk

17. Doctors advise shifting Nawaz to US for treatment

18. Enlarged lymph nodes detected in Nawaz's right axilla: Dr Adnan

20. New consensus on biomarkers for diagnosis of neurocognitive disorders.

21. APRINOIA Therapeutics Established Collaboration on Tau PET Imaging Tracer Development

23. UK Contract Notice: Medicines Discovery Catapult Issues Solicitation for 'The Supply, Delivery, Installation and Maintenance of a Positron Emission Tomography Imaging System'

24. Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent

25. FDA Approves First Agent for PSMA-PET Imaging in Prostate Cancer

26. FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer

27. United States : FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer

28. FDA APPROVES FIRST PSMA-TARGETED PET IMAGING DRUG FOR MEN WITH PROSTATE CANCER

31. John Hunter Hospital - Design Finalisation And Construction - Pet Scanner Works

33. Blue Earth Diagnostics Announces First Patient Doses of PET Imaging Agent rhPSMA-7.3 (18F) in Collaboration with Nucleis Radiopharmaceuticals in Liege, Belgium

34. EU Contract Notice: JZU University institute of positron emission tomography Issues contract notice|solicitation for 'North Macedonia-Skopje: Medical equipments, pharmaceuticals and personal care products'

35. NSK linear motion systems provide 'clear' benefits for medical imaging systems

36. Scientists expand PET imaging options through simpler chemistry

37. Deliveries Of Radiopharmaceuticals Naf For Positron Emission Tomography Nnh

38. Deliveries Of Naf Radiopharmaceuticals For Nnh Positron Emission Tomography

39. Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL[TM] (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent

41. Leading Physicians Highlight Groundbreaking Potential of Radiopharmaceuticals in Oncology and Need for Expanded Patient Access

45. Blue Earth Diagnostics Announces Dosing of Initial Patients in Phase 3 SPOTLIGHT Clinical Trial of Targeted PET Imaging Agent rhPSMA-7.3 (18F) in Biochemically Recurrent Prostate Cancer

47. Blue Earth Diagnostics Announces Dosing of Initial Patients in Phase 3 SPOTLIGHT Clinical Trial of Targeted PET Imaging Agent rhPSMA-7.3 (18F) in Biochemically Recurrent Prostate Cancer

48. Blue Earth Diagnostics Announces Dosing of Initial Patients in Phase 3 SPOTLIGHT Clinical Trial of Targeted PET Imaging Agent rhPSMA-7.3 (18F) in Biochemically Recurrent Prostate Cancer

49. Supply Of Radiopharmaceuticals For Positron Emission Tomography

Catalog

Books, media, physical & digital resources